Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Baricitinib is the most effective treatment for alopecia areata.

Pranlukast and mirabegron may work as new diabetes drugs.

JAK inhibitors are effective for long-term management of alopecia areata.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A man developed skin issues from cancer medication, which improved with specific treatments.

Ozenoxacin reduces sebum production, helping manage acne.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Certain medications like α1-blockers, benzodiazepines, and finasteride increase the risk of floppy iris syndrome during cataract surgery.

Minoxidil sulfate relaxes blood vessels by increasing potassium permeability.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Atropine and neosynephrine effectively prevent floppy iris syndrome during cataract surgery.

Entospletinib effectively prevents eye and skin GVHD in mice.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

JAK inhibitors might help treat alopecia areata.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Ruxolitinib treatment may cause eyelash growth.

Janus kinase inhibitors may help treat lichen planopilaris.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.